Turbine Company

Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutic targets or indications, untangling the complexity of cancer.
Technology: Artificial Intelligence, Biopharma, Biotechnology
Industry: AI for Longevity, Early Drug Development
Headquarters: Budapest, Budapest, Hungary
Founded Date: 2015-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 10
Total Funding: 10314464
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-01-07
Last Funding Type: Series A

Visit Website
Register and Claim Ownership